Treat and Reduce Obesity Act of 2023

Dec 27, 2024
Dec 27, 2024

Summary

Allows Medicare to pay for more types of health workers to provide obesity therapy and covers certain weight-loss drugs for seniors.

What problem does this solve?

Obesity is a growing and expensive health problem for older Americans, leading to many other diseases and high medical costs. This bill expands Medicare coverage to include more treatments and medications, helping more seniors get the care they need.

What does this bill do?

Expands providers for obesity therapy
Allows Medicare to cover intensive behavioral therapy for obesity from more providers, including specialists, physician assistants, nurse practitioners, dietitians, and approved community programs.
Adds Medicare coverage for obesity drugs
Requires Medicare Part D to cover drugs used for treating obesity or for weight loss management in overweight people who have other related health problems.
Requires coordinated care
Requires that therapy from new providers like dietitians or community programs must be based on a referral from a physician and that treatment plans are shared back with the referring doctor.
Mandates reports to Congress
Requires the Secretary of Health and Human Services to report to Congress every two years on the progress of these changes and suggest ways to improve obesity care.

Who does this affect?

  • Medicare beneficiaries
  • Healthcare providers
  • Pharmaceutical companies

What is the real world impact?

Improves access to obesity care for seniors
Provides more options for Medicare beneficiaries to receive treatment for obesity, including counseling and medication, which could improve their health and quality of life.
Reduces long-term healthcare costs
Aims to lower future Medicare spending on chronic diseases linked to obesity, like heart disease and diabetes, by treating obesity proactively.
Increases profits for drug companies
Requires Medicare Part D to cover weight-loss drugs, creating a large new market for pharmaceutical companies that produce these medications, which could lead to higher government spending.

When does this start?

This bill has different start dates for its key parts, including a two-year delay for drug coverage.
Medicare Part D coverage for obesity drugs
Coverage for obesity medication will begin for plan years starting two years or more after this act becomes law.
First report to Congress
The Secretary of Health and Human Services must submit the first report on the act's progress no later than one year after it becomes law.